343
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Expanding the evidence for managing metformin poisoning to support decision-making

ORCID Icon & ORCID Icon
Pages 203-206 | Received 21 Mar 2023, Accepted 23 Mar 2023, Published online: 02 May 2023

References

  • Mikulic M. Number of metformin prescriptions in the U.S. 2004-2020; 2023 Mar 20. Available from: https://www.statista.com/statistics/780332/metformin-hydrochloride-prescriptions-number-in-the-us/2022
  • Duong JK, Furlong TJ, Roberts DM, et al. The role of metformin in Metformin-Associated lactic acidosis (MALA): case series and formulation of a model of pathogenesis. Drug Saf. 2013;36(9):733–746.
  • Juurlink DN, Roberts DM. The enigma of metformin-associated lactic acidosis. Clin Toxicol. 2014;52(2):85–87.
  • Corchia A, Wynckel A, Journet J, et al. Metformin-related lactic acidosis with acute kidney injury: results of a French observational multicenter study. Clin Toxicol. 2020;58(5):375–382.
  • Aharaz A, Pottegård A, Henriksen DP, et al. Risk of lactic acidosis in type 2 diabetes patients using metformin: a case control study. PLoS One. 2018;13(5):e0196122.
  • Theobald J, Schneider J, Cheema N, et al. Time to development of metformin-associated lactic acidosis. Clin Toxicol. 2020;58(7):758–762.
  • Peña Porta JM, Villafuerte Ledesma HM, Vicente de Vera Floristán C, et al. Incidence, factors related to presentation, course and mortality of metformin-associated lactic acidosis in the healthcare area of a tertiary hospital. Nefrologia (Engl Ed). 2019;39(1):35–43.
  • van Berlo-van de Laar IRF, Vermeij CG, van den Elsen-Hutten M, et al. Extracorporeal treatment of metformin-associated lactic acidosis in clinical practice: a retrospective cohort study. Eur J Clin Pharmacol. 2020;76(6):815–820.
  • Blumenberg A, Benabbas R, Sinert R, et al. Do patients die with or from metformin-associated lactic acidosis (MALA)? systematic review and meta-analysis of pH and lactate as predictors of mortality in MALA. J Med Toxicol. 2020;16(2):222–229. Apr
  • Thammavaranucupt K, Phonyangnok B, Parapiboon W, et al. Metformin-associated lactic acidosis and factors associated with 30-day mortality. PLoS One. 2022;17(8):e0273678.
  • Juneja D, Nasa P, Jain R. Metformin toxicity: a meta-summary of case reports. World J Diabetes. 2022;13(8):654–664.
  • Calello DP, Liu KD, Wiegand TJ, et al. Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the Extracorporeal Treatments in Poisoning Workgroup. Crit Care Med. 2015;43(8):1716–1730.
  • Doenyas-Barak K, Beberashvili I, Marcus R, et al. Lactic acidosis and severe septic shock in metformin users: a cohort study. Crit Care. 2016;20:10.
  • Peters N, Jay N, Barraud D, et al. Metformin-associated lactic acidosis in an intensive care unit. Crit Care. 2008;12(6):R149.
  • Trebach J, Mohan S, Gnirke M, et al. Retrospective evaluation of management guidelines for extracorporeal treatment of metformin poisoning. Clin Toxicol. 2023;8:1–5.
  • Stefani M, Roberts DM. Complex decisions in the use of extracorporeal treatments in acute metformin overdose: which modality, when and how to measure the effect. Br J Clin Pharmacol. 2018;84(12):2689–2691.
  • Reynolds HV, Pollock HHG, Apte YV, et al. Achieving high dialysis dose via continuous renal replacement therapy in the setting of metformin associated lactic acidosis. A A Pract. 2022;16(1):e01561.
  • Correia MS, Horowitz BZ. Continuous extracorporeal clearance in metformin-associated lactic acidosis and metformin-induced lactic acidosis: a systematic review. Clin Toxicol. 2022;60(11):1266–1276.
  • Chiew AL, Wright DFB, Dobos NM, et al. Massive’ metformin overdose. Br J Clin Pharmacol. 2018;84(12):2923–2927.
  • Seube PA, Djerada Z, Konecki C, et al. Simultaneous, dual continuous veno-venous haemofiltration for refractory metformin-induced lactic acidosis: a case report. Clin Toxicol. 2023;3:1–2.
  • Ayoub P, Hétu PO, Cormier M, et al. Toxicokinetics of metformin during hemodialysis. Kidney Int Rep. 2017;2(4):759–762.
  • Pearlman BL, Fenves AZ, Emmett M. Metformin-associated lactic acidosis. Am J Med. 1996;101(1):109–110.
  • Yeh HC, Ting IW, Tsai CW, et al. Serum lactate level and mortality in metformin-associated lactic acidosis requiring renal replacement therapy: a systematic review of case reports and case series. BMC Nephrol. 2017;18(1):229.
  • Demaretz L, Claisse G, Fanton DC, et al. Relationship between plasmatic metformin concentration and renal replacement therapy: a multicenter cohort study. Ther Drug Monit. 2022;44(6):791–796.
  • Boucaud-Maitre D, Ropers J, Porokhov B, et al. Lactic acidosis: relationship between metformin levels, lactate concentration and mortality. Diabet Med. 2016;33(11):1536–1543.
  • McNamara K, Isbister GK. Hyperlactataemia and clinical severity of acute metformin overdose. Intern Med J. 2015;45(4):402–408.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.